MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 38 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $566,000 | -30.0% | 278,600 | -25.6% | 0.01% | +18.2% |
| Q4 2019 | $809,000 | +200.7% | 374,400 | +114.7% | 0.01% | +175.0% |
| Q3 2019 | $269,000 | -65.1% | 174,400 | -6.0% | 0.00% | -60.0% |
| Q2 2019 | $770,000 | +35.8% | 185,600 | +36.9% | 0.01% | +42.9% |
| Q1 2019 | $567,000 | +175.2% | 135,600 | +89.1% | 0.01% | +133.3% |
| Q4 2018 | $206,000 | -81.6% | 71,706 | -35.8% | 0.00% | -72.7% |
| Q3 2018 | $1,117,000 | +174.4% | 111,706 | +93.9% | 0.01% | +175.0% |
| Q2 2018 | $407,000 | +667.9% | 57,606 | +92.0% | 0.00% | +300.0% |
| Q1 2017 | $53,000 | +76.7% | 30,000 | 0.0% | 0.00% | – |
| Q4 2016 | $30,000 | -45.5% | 30,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $55,000 | -42.7% | 30,000 | -60.3% | 0.00% | 0.0% |
| Q2 2016 | $96,000 | -64.7% | 75,500 | +49.5% | 0.00% | -80.0% |
| Q1 2016 | $272,000 | -29.5% | 50,500 | 0.0% | 0.01% | -28.6% |
| Q4 2015 | $386,000 | +9.0% | 50,500 | +18.8% | 0.01% | 0.0% |
| Q3 2015 | $354,000 | +1.7% | 42,500 | +41.7% | 0.01% | 0.0% |
| Q2 2015 | $348,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
| Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
| New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
| 683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
| Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
| Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
| THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
| Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
| Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
| GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |